A: When traveling across time zones with once-a-week GLP-1 medications, maintain consistency in the day of the week you take your medication
Gene-expression markers (in-vitro): Reports describe changes in c-Fos, HSP70 and SOD in cell models mechanistic observations, not clinical outcomes [5]
Exclusion criteria included unreliably extracted data, non-English language studies, books, conference papers, case reports, and articles without full text, and non-original articles like reviews and meta-analyses
TRIUMPH-4, the first Phase 3 obesity readout (Dec 2025), reported about 28.7% mean weight loss at the top dose at 76 weeks the largest figure seen in any GLP-class trial so far
Learn more about our findings and our methodology below
In addition, cost metrics such as cost per kilogram of weight loss may overlook indirect costs and long-term healthcare savings associated with sustained weight loss